Tuberculosis in poorly controlled type 2 diabetes: Altered cytokine expression in peripheral white blood cells

Clinical Infectious Diseases

Volumn 47, Issue 5, 2008, Pages 634-641

  Restrepo, Blanca I ^a   Fisher Hoch, Susan P ^a   Pino, Paula A ^a   Salinas, Adrian ^a   Rahbar, Mohammad H ^a,b,d   Mora, Francisco ^e   Cortes Penfield, Nicolas ^c   McCormick, Joseph B ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b Center for Clinical and Translational Sciences   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e SECRETARÍA DE SALUD   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOSYLATED HEMOGLOBIN; MYCOBACTERIUM ANTIGEN; TUBERCULIN;

ADAPTIVE IMMUNITY; ARTICLE; CYTOKINE RELEASE; HYPERGLYCEMIA; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; INFECTION SENSITIVITY; INNATE IMMUNITY; LEUKOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TUBERCULOSIS;

ADULT; AGED; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN; TUBERCULOSIS; YOUNG ADULT;

EID: 49449095676     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/590565     Document Type: Article

References (41)

1. Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol 2006; 35:93-9.
2. Restrepo BI. Convergence of the tuberculosis and diabetes epidemics: renewal of old acquaintances. Clin Infect Dis 2007; 45:436-8.
3. Ponce-De-Leon A, Garcia-Garcia MdL, Garcia-Sancho MC,et al. Tuberculosis and diabetes in southern Mexico. Diabetes Care 2004; 27:1584-90.
4. Sentochnik D, Eliopoulos M. Infection and diabetes. In: Kahn C, Weir GC, eds. Joslin's diabetes mellitus. Philadelphia: Lea & Febiger, 1994: 867-88.
5. Llorente L, De La Fuente H, Richaud-Patin Y, et al. Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology. Immunol Lett 2000; 74:239-44.
6. Chang FY, Shaio MF. Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1995; 28:137-46.
7. Josefsen K, Nielsen H, Lorentzen S, Damsbo P, Buschard K. Circulating monocytes are activated in newly diagnosed type 1 diabetes mellitus patients. Clin Exp Immunol 1994; 98:489-93.
8. Scatena R, Nocca G, De Sole P, Bottoni P, Giardina B. Impaired reactive oxygen metabolism of phagocytic leukocytes in NIDDM patients: a role for non-enzymatic glycosylation of collagen. J Biolumin Chemilumin 1998; 13:273-8.
9. Jansen A, van Hagen M, Drexhage HA. Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 1995; 345:491-2.
10. Bagdade JD, Nielson KL, Bulger RJ. Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci 1972; 263:451-6.
11. Parkkonen P, Hyoty H, Huupponen T, Leinikki P, Tuomilehto-Wolf E, Knip M. Defective HLA class II expression in monocytes of type 1 diabetic patients. The Childhood Diabetes in Finland Study Group. Apmis 1993; 101:395-402.
12. Romano-Carratelli C, Galdiero M, Bentivoglio C, Nuzzo I, Cozzolino D, Torella R. HLA class II antigens and interleukin-1 in patients affected by type-II diabetes mellitus and hyperlipemia. J Med 1993; 24:28-34.
13. Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000; 49:1451-8.
14. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26:259-65.
15. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41:1241-8.
16. MacRury SM, Gemmell CG, Paterson KR, MacCuish AC. Changes in phagocytic function with glycaemic control in diabetic patients. J Clin Pathol 1989; 42:1143-7.
17. Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence: a reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978; 27:677-81.
18. Turner J, Frank AA, Brooks JV, Gonzalez-Juarrero M, Orme IM. The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4. Exp Gerontol 2001; 36:537-45.
19. Johnson CM, Cooper AM, Frank AA, Bonorino CB, Wysoki LJ, Orme IM. Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice. Tuber Lung Dis 1997; 78:257-61.
20. Randhawa PS. Lymphocyte subsets in granulomas of human tuberculosis: an in situ immunofluorescence study using monoclonal antibodies. Pathology 1990; 22:153-5.
21. Bosio CM, Gardner D, Elkins KL. Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology. J Immunol 2000; 164:6417-25.
22. Estaquier J, Idziorek T, Zou W, et al. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J Exp Med 1995; 182:1759-67.
23. Rosenzweig SD, Holland SM. Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 2005; 203:38-47.
24. Martens GW, Arikan MC, Lee J, Ren F, Greiner D, Kornfeld H. Tuberculosis susceptibility of diabetic mice. Am J Respir Cell Mol Biol 2007; 37:518-24.
25. Instituto Nacional de Salud Pública, Secretaría de Salud de México. Encuesta Nacional de Salud 2000. México: Instituto Nacional de Salud Pública, 2003.
26. Texas Department of State and Health Services. Behavioral risk factor surveillance system (Texas-Region 11). 2002.
27. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163:1009-21.
28. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan DM, Peterson CM. Tests of glycemia in diabetes. Diabetes Care 2004; 27(Suppl 1):S91-3.
29. + memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis. J Immunol 1998; 161:5284-95.
30. Hanekom WA, Hughes J, Mavinkurve M, et al. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J Immunol Methods 2004; 291:185-95.
31. Standards of medical care in diabetes-2006. Diabetes Care 2006; 29(Suppl 1):S4-42.
32. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2002; 25:750-86.
33. Viardot A, Grey ST, Mackay F, Chisholm D. Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 2007; 148:346-53.
34. Lapolla A, Tonani R, Fedele D, et al. Non-enzymatic glycation of IgG: an in vivo study. Horm Metab Res 2002; 34:260-4.
35. Greenhalgh CJ, Hilton DJ. Negative regulation of cytokine signaling. J Leukoc Biol 2001; 70:348-56.
36. Tamarat R, Silvestre JS, Huijberts M, et al. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc Natl Acad Sci U S A 2003; 100:8555-60.
37. Restrepo BI, Fisher-Hoch SP, Crespo JG, et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 2006; 135:1-9.
38. Briken V, Porcelli SA, Besra GS, Kremer L. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 2004; 53:391-403.
39. Bhatt K, Salgame P. Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol 2007; 27:347-62.
40. Stalenhoef JE, Alisjahbana B, Nelwan EJ, et al. The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 2007; 27:97-103.
41. Tsukaguchi K, Okamura H, Matsuzawa K, et al. Longitudinal assessment of IFN-gamma production in patients with pulmonary tuberculosis complicated with diabetes mellitus [in Japanese]. Kekkaku 2002; 77:409-13.